196 related articles for article (PubMed ID: 35554594)
21. Hypocretin and human African trypanosomiasis.
Dauvilliers Y; Bisser S; Chapotot F; Vatunga G; Cespuglio R; Josenando T; Buguet A
Sleep; 2008 Mar; 31(3):348-54. PubMed ID: 18363311
[TBL] [Abstract][Full Text] [Related]
22. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
[TBL] [Abstract][Full Text] [Related]
23. Narcolepsies, update in 2023.
Barateau L; Pizza F; Chenini S; Peter-Derex L; Dauvilliers Y
Rev Neurol (Paris); 2023 Oct; 179(7):727-740. PubMed ID: 37634997
[TBL] [Abstract][Full Text] [Related]
24. CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway.
Heier MS; Evsiukova T; Vilming S; Gjerstad MD; Schrader H; Gautvik K
Sleep; 2007 Aug; 30(8):969-73. PubMed ID: 17702265
[TBL] [Abstract][Full Text] [Related]
25. [Comparative analysis of patients with narcolepsy-cataplexy, narcolepsy without cataplexy and idiopathic hypersomnia].
MartÃnez-RodrÃguez JE; Iranzo A; Casamitjana R; Graus F; Santamaria J
Med Clin (Barc); 2007 Mar; 128(10):361-4. PubMed ID: 17386240
[TBL] [Abstract][Full Text] [Related]
26. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.
Kanbayashi T; Inoue Y; Chiba S; Aizawa R; Saito Y; Tsukamoto H; Fujii Y; Nishino S; Shimizu T
J Sleep Res; 2002 Mar; 11(1):91-3. PubMed ID: 11869432
[TBL] [Abstract][Full Text] [Related]
27. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
28. Hypocretin deficiency develops during onset of human narcolepsy with cataplexy.
Savvidou A; Knudsen S; Olsson-Engman M; Gammeltoft S; Jennum P; Palm L
Sleep; 2013 Jan; 36(1):147-8. PubMed ID: 23288981
[TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy.
Heier MS; Jansson TS; Gautvik KM
J Clin Sleep Med; 2011 Dec; 7(6):653-8. PubMed ID: 22171205
[TBL] [Abstract][Full Text] [Related]
30. Narcolepsy with Cataplexy in an Elderly Woman.
Suzuki S; Uehara T; Ohira Y; Ikusaka M
J Gen Intern Med; 2015 Aug; 30(8):1222-4. PubMed ID: 25784528
[TBL] [Abstract][Full Text] [Related]
31. HLA-DQB1 allele and hypocretin in Korean narcoleptics with cataplexy.
Jeong JH; Hong SC; Shin YK; Han JH; Lee SP
J Korean Med Sci; 2007 Feb; 22(1):127-31. PubMed ID: 17297265
[TBL] [Abstract][Full Text] [Related]
32. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ
J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284
[TBL] [Abstract][Full Text] [Related]
33. Presentations of primary hypersomnia in Chinese children.
Han F; Lin L; Li J; Aran A; Dong SX; An P; Zhao L; Li M; Li QY; Yan H; Wang JS; Gao HY; Li M; Gao ZC; Strohl KP; Mignot E
Sleep; 2011 May; 34(5):627-32. PubMed ID: 21532956
[TBL] [Abstract][Full Text] [Related]
34. Sleep transitions in hypocretin-deficient narcolepsy.
Sorensen GL; Knudsen S; Jennum P
Sleep; 2013 Aug; 36(8):1173-7. PubMed ID: 23904677
[TBL] [Abstract][Full Text] [Related]
35. HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency.
Han F; Lin L; Schormair B; Pizza F; Plazzi G; Ollila HM; Nevsimalova S; Jennum P; Knudsen S; Winkelmann J; Coquillard C; Babrzadeh F; Strom TM; Wang C; Mindrinos M; Fernandez Vina M; Mignot E
Sleep; 2014 Oct; 37(10):1601-8. PubMed ID: 25197808
[TBL] [Abstract][Full Text] [Related]
36. Narcolepsy in African Americans.
Kawai M; O'Hara R; Einen M; Lin L; Mignot E
Sleep; 2015 Nov; 38(11):1673-81. PubMed ID: 26158891
[TBL] [Abstract][Full Text] [Related]
37. A series of 7 cases of patients with narcolepsy with hypocretin deficiency without the HLA DQB1*06:02 allele.
Miano S; Barateau L; De Pieri M; Riccardi S; Thevenin C; Manconi M; Dauvilliers Y
J Clin Sleep Med; 2023 Dec; 19(12):2053-2057. PubMed ID: 37539640
[TBL] [Abstract][Full Text] [Related]
38. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy.
Nishino S; Ripley B; Overeem S; Nevsimalova S; Lammers GJ; Vankova J; Okun M; Rogers W; Brooks S; Mignot E
Ann Neurol; 2001 Sep; 50(3):381-8. PubMed ID: 11558795
[TBL] [Abstract][Full Text] [Related]
39. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
[TBL] [Abstract][Full Text] [Related]
40. [Predictive value of typical cataplexy+ DQB1*0602 positive to hypocretin-1 reduction in cerebrospinal fluid in patients with narcolepsy].
Chang Y; Dong XS; Li J; Zhang XZ; Yan H; Zhang W; Zhao L; Zuo YH; Yu YB; Dou YL; Feng JJ; Han F
Zhonghua Yi Xue Za Zhi; 2018 Oct; 98(40):3253-3257. PubMed ID: 30392291
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
